PHASE I DOSE-ESCALATION TRIAL OF MULTIPLE AND FRACTIONATED-DOSE PSMA-TARGETED ALPHA RADIONUCLIDE (225AC-J591) FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Sun, Michael
Nauseef, Jones
Fajardo, Andres Ricaurte
Davidson, Zachary
Thomas, Joseph
Ruder, Samuel
Stangl-Kremser, Judith
Castellanos, Sandra Huicochea
Molina, Ana
Sternberg, Cora
Patel, Amie
Yuan, Sarah
Fernandez, Escarleth
Fung, Edward
Avlonitis, Vasilios
O'Dwyer, Elisabeth
Nanus, David
Osborne, Joseph
Bander, Neil
Tagawa, Scott
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
10.1097/01.JU.0001009540.33579.43.11
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD01-11
引用
收藏
页码：E67 / E68
页数：2
相关论文
共 50 条
  • [21] Final results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC).
    Tagawa, Scott T.
    Thomas, Charlene
    Nauseef, Jones T.
    Sartor, A. Oliver
    Sun, Michael Philip
    Castellanos, Sandra Huicochea
    Fajardo, Andres Ricaurte
    Beltran, Himisha
    Demichelis, Francesca
    Sigouros, Michael
    Orlando, Francesco
    Molina, Ana M.
    Davidson, Zachary
    Patel, Amie
    Lewis, Brian E.
    Nanus, David M.
    Vallabhajosula, Shankar
    Bander, Neil Harrison
    Osborne, Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Preliminary results of a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)
    Tagawa, S. T.
    Osborne, J. R.
    Hackett, A.
    Niaz, M. J.
    Cooley, V.
    Christos, P.
    Vlachostergios, P. J.
    Thomas, C.
    Gracey, L.
    Beltran, H.
    Molina, A. M.
    Nanus, D. M.
    Babich, J.
    Vallabhajosula, S.
    Sartor, O.
    Ballman, K.
    Bander, N. H.
    ANNALS OF ONCOLOGY, 2019, 30
  • [23] A phase I dose-escalation study of LAE001 in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Ye, D.
    Liu, R.
    Luo, H.
    Han, W.
    Lu, X.
    Cao, L.
    Guo, P.
    Liu, J.
    Yue, Y.
    Lu, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S643 - S643
  • [24] Phase I trial of fractionated-dose 177Lutetium radiolabeled anti-prostate-specific membrane antigen monoclonal antibody J591 (177Lu-J591) in patients with metastatic castration-resistant prostate cancer (metCRPC)
    Tagawa, Scott T.
    Vallabhajosula, Shankar
    Akhtar, Naveed H.
    Osborne, Joseph
    Beltran, Himisha
    Saran, Ankeeta
    Mileo, Gina
    Ecker, Caryn
    Goldsmith, Stanley J.
    Nanus, David M.
    Bander, Neil H.
    CANCER RESEARCH, 2012, 72
  • [25] A phase I dose-escalation trial of AEZS-108 in taxane- and castration-resistant prostate cancer (CRPC)
    Pinski, Jacek K.
    Schally, Andrew V.
    Tsao-Wei, Denice D.
    Dorff, Tanya B.
    Groshen, Susan G.
    Xiong, Shigang
    Quinn, David I.
    Tai, Yu-Chong
    Engel, Juergen
    Liu, Stephen V.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] Phase I dose-escalation study of docetaxel/predisone and fractionated 177Lu-J591 for metastatic castrate-resistant prostate cancer (metCRPC)
    Beltran, H.
    Vallabhajosula, S.
    Kelly, W. K.
    Whang, Y. E.
    Osborne, J.
    Petrillo, K.
    Goldsmith, S. J.
    Bander, N. H.
    Nanus, D. M.
    Tagawa, S. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Advances in 177Lu-PSMA and 225Ac-PSMA Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
    Ling, Sui Wai
    de Blois, Erik
    Hooijman, Eline
    van der Veldt, Astrid
    Brabander, Tessa
    PHARMACEUTICS, 2022, 14 (10)
  • [28] Patient-reported outcomes (PRO) from a phase I/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration-resistant prostate cancer (mCRPC)
    Vlachostergios, Panagiotis J.
    Goswami, Sukanya
    Niaz, Muhammad Junaid
    Thomas, Charlene
    Christos, Paul J.
    Osborne, Joseph
    Vallabhajosula, Shankar
    Molina, Ana M.
    Sternberg, Cora N.
    Singh, Sharon
    Tan, Angela
    Patel, Amie
    Nanus, David M.
    Bander, Neil Harrison
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [29] Efficacy and safety of 225Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients
    Yadav, Madhav Prasad
    Ballal, Sanjana
    Sahoo, Ranjit Kumar
    Tripathi, Madhavi
    Seth, Amlesh
    Bal, Chandrasekhar
    THERANOSTICS, 2020, 10 (20): : 9364 - 9377
  • [30] Efficacy and Safety of 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer Patients
    Yadav, M.
    Ballal, S.
    Bal, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S420 - S420
12345